Response to therapy
| EBMT criteria . | ≤ 5% N = PC/BMPC . | > 5% N = PC/BMPC . | P . | |||
|---|---|---|---|---|---|---|
| After induction . | After ASCT . | After induction . | After ASCT . | After induction . | After ASCT . | |
| CR | 56 (11%) | 168 (33%) | 17 (21%) | 51 (64%) | .01 | < .001 |
| nCR | 61 (12%) | 99 (19%) | 19 (24%) | 8 (10%) | .005 | < .001 |
| PR or less | 397 (77%) | 247 (48%) | 44 (55%) | 21 (26%) | < .001 | < .001 |
| EBMT criteria . | ≤ 5% N = PC/BMPC . | > 5% N = PC/BMPC . | P . | |||
|---|---|---|---|---|---|---|
| After induction . | After ASCT . | After induction . | After ASCT . | After induction . | After ASCT . | |
| CR | 56 (11%) | 168 (33%) | 17 (21%) | 51 (64%) | .01 | < .001 |
| nCR | 61 (12%) | 99 (19%) | 19 (24%) | 8 (10%) | .005 | < .001 |
| PR or less | 397 (77%) | 247 (48%) | 44 (55%) | 21 (26%) | < .001 | < .001 |
Results are expressed as number (percentage) of cases. N = PC indicates normal plasma cells; BMPC, bone marrow plasma cells; and ASCT, autologus stem cell transplantation.